BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38747849)

  • 1. SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient.
    Mendes-Correa MC; Ghilardi FR; Salomão MC; Villas-Boas LS; Paula AV; Paiao HGO; Costa ACD; Tozetto-Mendoza TR; Freire W; Sales FCS; Claro IM; Sabino EC; Faria NR; Witkin SS
    Rev Inst Med Trop Sao Paulo; 2024; 66():e28. PubMed ID: 38747849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
    Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
    mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
    Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
    J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient.
    Alshukairi AN; El-Kafrawy SA; Dada A; Yasir M; Yamani AH; Saeedi MF; Aljohaney A; AlJohani NI; Bahaudden HA; Alam I; Gojobori T; Radovanovic A; Alandijany TA; Othman NA; Alsubhi TL; Hassan AM; Tolah AM; Al-Tawfiq JA; Zumla A; Azhar EI
    Int J Infect Dis; 2021 Sep; 110():267-271. PubMed ID: 34289407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.
    Truong TT; Ryutov A; Pandey U; Yee R; Goldberg L; Bhojwani D; Aguayo-Hiraldo P; Pinsky BA; Pekosz A; Shen L; Boyd SD; Wirz OF; Röltgen K; Bootwalla M; Maglinte DT; Ostrow D; Ruble D; Han JH; Biegel JA; Li M; Huang C; Sahoo MK; Pannaraj PS; O'Gorman M; Judkins AR; Gai X; Dien Bard J
    EBioMedicine; 2021 May; 67():103355. PubMed ID: 33915337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
    Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
    Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
    Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.
    Murata T; Sakurai A; Suzuki M; Komoto S; Ide T; Ishihara T; Doi Y
    mSphere; 2021 May; 6(3):. PubMed ID: 34011679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
    Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
    J Infect Dis; 2022 Apr; 225(7):1118-1123. PubMed ID: 34940844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk.
    Leitão IC; Calil PT; Galliez RM; Moreira FRR; Mariani D; Castiñeiras ACP; da Silva GPD; Maia RA; Corrêa IA; Monteiro FLL; de Souza MRM; Gonçalves CCA; Higa LM; de Jesus Ribeiro L; Fonseca VWP; Bastos VC; Voloch CM; Faffe DS; da Costa Ferreira O; Tanuri A; Castiñeiras TMPP; da Costa LJ;
    Microbiol Spectr; 2021 Dec; 9(3):e0085521. PubMed ID: 34787498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
    Leung WF; Chorlton S; Tyson J; Al-Rawahi GN; Jassem AN; Prystajecky N; Masud S; Deans GD; Chapman MG; Mirzanejad Y; Murray MCM; Wong PHP
    Int J Infect Dis; 2022 Jan; 114():178-182. PubMed ID: 34757008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.
    Brandolini M; Zannoli S; Gatti G; Arfilli V; Cricca M; Dirani G; Denicolò A; Semprini S; Grumiro L; Imola M; Larne D; Marino MM; Manera M; Mancini A; Taddei F; Zagarrigo M; Biagetti C; Sambri V
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma: a case report.
    Maan I; Paraskevopoulou SM; Cwynarski K; Shrestha M; Waters L; Miller R; Ahmed N
    Infect Dis (Lond); 2022 Jul; 54(7):529-533. PubMed ID: 35348397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
    J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
    Rnjak D; Ravlić S; Šola AM; Halassy B; Šemnički J; Šuperba M; Hećimović A; Kurolt IC; Kurtović T; Mačak Šafranko Ž; Polančec D; Bendelja K; Mušlin T; Jukić I; Vuk T; Zenić L; Artuković M
    Transfus Clin Biol; 2021 Aug; 28(3):264-270. PubMed ID: 33901641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
    Tarhini H; Recoing A; Bridier-Nahmias A; Rahi M; Lambert C; Martres P; Lucet JC; Rioux C; Bouzid D; Lebourgeois S; Descamps D; Yazdanpanah Y; Le Hingrat Q; Lescure FX; Visseaux B
    J Infect Dis; 2021 May; 223(9):1522-1527. PubMed ID: 33556961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
    Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
    Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
    Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab.
    Van der Moeren N; Selhorst P; Ha M; Heireman L; Van Gaal PJ; Breems D; Meysman P; Laukens K; Verstrepen W; Van Gasse N; Ogunjimi B; Arien KK; Naesens R
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.